202 related articles for article (PubMed ID: 7804741)
21. [Anticoagulation and antiaggregation in cardiac patients].
Meyer BJ
Ther Umsch; 2003 Jan; 60(1):27-32. PubMed ID: 12638475
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
Little SH; Massel DR
Cochrane Database Syst Rev; 2003; (4):CD003464. PubMed ID: 14583979
[TBL] [Abstract][Full Text] [Related]
23. Oral anticoagulant treatment with and without aspirin.
Altman R; Rouvier J; Gurfinkel E
Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514
[TBL] [Abstract][Full Text] [Related]
24. [Antiplatelet therapy in cardiac diseases].
Aosaki M; Iwade K; Kimata S; Hosoda S
Nihon Rinsho; 1992 Feb; 50(2):397-402. PubMed ID: 1613997
[TBL] [Abstract][Full Text] [Related]
25. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
Antiplatelet Trialists' Collaboration
Br Med J (Clin Res Ed); 1988 Jan; 296(6618):320-31. PubMed ID: 3125883
[TBL] [Abstract][Full Text] [Related]
26. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
[TBL] [Abstract][Full Text] [Related]
27. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
Dörffler-Melly J; Koopman MM; Prins MH; Büller HR
Cochrane Database Syst Rev; 2005 Jan; (1):CD002071. PubMed ID: 15674891
[TBL] [Abstract][Full Text] [Related]
28. Antiplatelet therapy in the prevention of ischaemic stroke.
Verry M; Panak E; Cazenave JP
Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
[TBL] [Abstract][Full Text] [Related]
29. [Platelet antiaggregants in the treatment of arterial thrombosis].
Ferlito S
Minerva Cardioangiol; 1991 Oct; 39(10):375-89. PubMed ID: 1803283
[TBL] [Abstract][Full Text] [Related]
30. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
Yusuf S; Lessem J; Jha P; Lonn E
J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
[TBL] [Abstract][Full Text] [Related]
31. [Antiplatelet drugs for prevention of cerebral ischemic accidents].
Crassard I; Bousser MG
Rev Neurol (Paris); 1999 Sep; 155(8):531-41. PubMed ID: 10486843
[TBL] [Abstract][Full Text] [Related]
32. [Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease].
Magnani B; Semprini F
Cardiologia; 1994 Dec; 39(12 Suppl 1):15-21. PubMed ID: 7634259
[TBL] [Abstract][Full Text] [Related]
33. Drugs and surgery in the prevention of ischemic stroke.
Barnett HJ; Eliasziw M; Meldrum HE
N Engl J Med; 1995 Jan; 332(4):238-48. PubMed ID: 7808491
[TBL] [Abstract][Full Text] [Related]
34. Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction.
Bosch X; Marrugat J
Cochrane Database Syst Rev; 2001; (4):CD002130. PubMed ID: 11687143
[TBL] [Abstract][Full Text] [Related]
35. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.
Ridker PM; Manson JE; Gaziano JM; Buring JE; Hennekens CH
Ann Intern Med; 1991 May; 114(10):835-9. PubMed ID: 2014943
[TBL] [Abstract][Full Text] [Related]
36. Antithrombotic drugs for the secondary prevention of ischemic stroke.
Nenci GG; Goracci S
Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
[TBL] [Abstract][Full Text] [Related]
37. [Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Dörffler-Melly J; Schmidli J; Mahler F
Ther Umsch; 2003 Jan; 60(1):36-42. PubMed ID: 12638477
[TBL] [Abstract][Full Text] [Related]
38. Antiplatelet therapy and anticoagulation in patients with hypertension.
Griffin G
Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
[TBL] [Abstract][Full Text] [Related]
39. Antiplatelet therapy in the prevention of stroke.
Easton JD
Drugs; 1991; 42 Suppl 5():39-50. PubMed ID: 1726215
[TBL] [Abstract][Full Text] [Related]
40. Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) group.
De Schryver EL
Cerebrovasc Dis; 2000; 10(2):147-50. PubMed ID: 10686454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
